![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
YC Cheng and K Nakayama
5-Fluoro-2'-deoxyuridine at a concentration of 0.1 microM completely inhibited incorporation of radioactivity from [3H]dUrd into DNA in HeLa S3 cells within 5 min of exposure. The dTTP pool size decreased from 800 to 300 pmoles/10(7) cells by 1 hr, and then gradually increased after 3 hr of exposure. Although the incorporation of radioactivity from [32P] H3PO4 into DNA was inhibited, the relative incorporation into smaller fragments compared with larger fragments of DNA was found to be increased in the drug-treated cells. When the cells with [14C]thymidine-prelabeled DNA were exposed to 5 fluoro-dUrd, shifts of labeled DNA peaks to smaller sizes were observed between 5 and 18 hr after exposure, as analyzed by alkaline sucrose gradient centrifugation. Exposure of cells to 1 and 10 microM 5-fluoro-[3H]dUrd caused incorporation of radioactivity into DNA. By high-performance liquid chromatographic analysis of nucleosides, it was confirmed that almost all of the radioactivity was incorporated as 5-fluoro-dUrd.
This article has been cited by other articles:
|
|
 |
|
  H. Nakagawa, N. Maeda, T. Tsuzuki, T. Suzuki, A. Hirayama, E. Miyahara, and K. Wada Intracavitary Chemotherapy with 5-Fluoro-2'-deoxyuridine (FdUrd) in Malignant Brain Tumors Jpn. J. Clin. Oncol., June 1, 2001; 31(6): 251 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Parsels, R. C. Zellars, T. L. Loney, J. D. Parsels, M. F. Clarke, A. K. Merchant, T. S. Lawrence, and J. Maybaum Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype Mol. Pharmacol., October 1, 1997; 52(4): 600 - 605. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
